BioCryst Pharmaceuticals

Youtube Subscribe

Open: 7.5 Close: 7.65 Change: 0.15

Our AI found 5 flaws in BioCryst Pharmaceuticals Company Inc Stock.

This document will help you to evaluate BioCryst Pharmaceuticals without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about BioCryst Pharmaceuticals are: Pharmaceuticals, Inc, BioCryst, NASDAQBCRX, Get, Free, Report, …

Concept Map

Semantic Network

Stock Summary

BioCryst Pharmaceuticals, Inc. discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.

Today's Summary

BioCryst Pharmaceuticals ( NASDAQ:BCRX – Get Free Report ) last posted its quarterly earnings data on Thursday, August 3rd. Revenue for the quarter was up 24.2% on a year-over-year. The key participants in the market are Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc. and Nobelpharma Co., Ltd.. Biocryst Pharmaceuticals inc. advanced charts | bcrx | barrons.

Today's News

BioCryst Pharmaceuticals ( NASDAQ:BCRX – Get Free Report ) last posted its quarterly earnings data on Thursday, August 3rd. Revenue for the quarter was up 24.2% on a year-over-year. The key participants in the market are Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc. and Nobelpharma Co., Ltd.. Biocryst Pharmaceuticals inc. advanced charts | bcrx | barrons.

Stock Profile

"BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor for complement-mediated diseases; and Galidesivir, to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina."

Keywords

Are looking for the most relevant information about BioCryst Pharmaceuticals? Investor spend a lot of time searching for information to make investment decisions in BioCryst Pharmaceuticals. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about BioCryst Pharmaceuticals are: Pharmaceuticals, Inc, BioCryst, NASDAQBCRX, Get, Free, Report, and the most common words in the summary are: biocryst, pharmaceutical, inc, stock, news, bcrx, price, . One of the sentences in the summary was: Revenue for the quarter was up 24.2% on a year-over-year. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #biocryst #pharmaceutical #inc #stock #news #bcrx #price.

Read more →

Youtube Subscribe

---